Robert Lim
United States Food and Drug Administration · 9 works · 4,423 citations · h-index 8
Top works
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients
- The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial
- Predictive biomarkers to improve treatment of metastatic colorectal cancer (mCRC): Outcomes with cetuximab plus FOLFIRI in the CRYSTAL trial
- Inhaled Corticosteroids and LABAs — Removal of the FDA’s Boxed Warning
- Outcomes of Adjuvant Chemoradiotherapy After a Radical Gastrectomy and a D2 Node Dissection for Gastric Adenocarcinoma
- Expanding Approved Patient Populations for Rare Disease Treatment Using In Vitro Data
- Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development
- Advancing Therapeutic Development for Pulmonary Morbidities Associated with Preterm Birth